基于DNA甲基化模式的甲状腺肿瘤分类
本研究采用无监督机器学习方法,仅依据DNA甲基化数据对810例甲状腺样本(发现集256例,验证集554例)进行分型,识别出正常样、滤泡样和甲状腺乳头状癌样三种甲基化亚型,这些亚型与组织学诊断及基因组驱动因素强烈相关,滤泡变异型甲状腺乳头状癌样本分属两个甲基化簇,提示其异质性。
要点
- 无监督算法仅凭甲基化谱将甲状腺样本分为正常样、滤泡样和PTC样三种亚型。
- 滤泡样亚型包含滤泡性腺瘤、滤泡性癌、嗜酸细胞腺瘤和嗜酸细胞癌;PTC样亚型包含经典型PTC和高细胞型PTC。
- 98.7%的BRAFV600E驱动癌症为PTC样,96.0%的RAS驱动癌症为滤泡样甲基化模式。
核心结论
- 甲状腺肿瘤的DNA甲基化谱可无监督分为正常样、滤泡样和PTC样三种亚型,与组织学诊断和基因组驱动因素强烈相关。
研究设计与样本
- 采用无监督机器学习方法进行类别发现,仅基于DNA甲基化数据分类,未提供临床或病理信息。
- 分析810例甲状腺样本,其中发现集256例,验证集554例,包括良恶性肿瘤及正常甲状腺组织。
主要发现
- 三种甲基化亚型与组织学诊断强烈相关(p < 0.001)。
- 滤泡性腺瘤、滤泡性癌、嗜酸细胞腺瘤和嗜酸细胞癌聚类形成滤泡样亚型;经典型PTC和高细胞型PTC聚类形成PTC样亚型。
- 98.7%的BRAFV600E驱动癌症为PTC样,96.0%的RAS驱动癌症为滤泡样甲基化模式。
- 滤泡变异型PTC样本分属滤泡样和PTC样两个甲基化簇;滤泡样甲基化模式的FVPTC样本富集RAS突变(36.4% vs. 8.0%;p < 0.001)。
- PTC样甲基化模式的FVPTC样本富集BRAFV600E突变(52.0% vs. 0%,Fisher精确检验p = 0.004)和RET融合(16.0% vs. 0%,Fisher精确检验p = 0.003)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Alterations in DNA methylation are stable epigenetic events that can serve as clinical biomarkers. The aim of this study was to analyze methylation patterns among various follicular cell-derived thyroid neoplasms to identify disease subtypes and help understand and classify thyroid tumors. Methods: We employed an unsupervised machine learning method for class discovery to search for distinct methylation patterns among various thyroid neoplasms. Our algorithm was not provided with any clinical or pathological information, relying exclusively on DNA methylation data to classify samples. We analyzed 810 thyroid samples (n = 256 for discovery and n = 554 for validation), including benign and malignant tumors, as well as normal thyroid tissue. Results: Our unsupervised algorithm identified that samples could be classified into three subtypes based solely on their methylation profile. These methylation subtypes were strongly associated with histological diagnosis (p < 0.001) and were therefore named normal-like, follicular-like, and papillary thyroid carcinoma (PTC)-like. Follicular adenomas, follicular carcinomas, oncocytic adenomas, and oncocytic carcinomas clustered together forming the follicular-like methylation subtype. Conversely, classic papillary thyroid carcinomas (cPTC) and tall cell PTC clustered together forming the PTC-like subtype. These methylation subtypes were also strongly associated with genomic drivers: 98.7% BRAFV600E-driven cancers were PTC like, whereas 96.0% RAS-driven cancers had a follicular-like methylation pattern. Interestingly, unlike other diagnoses, follicular variant PTC (FVPTC) samples were split into two methylation clusters (follicular like and PTC like), indicating a heterogeneous group likely to be formed by two distinct diseases. FVPTC samples with a follicular-like methylation pattern were enriched for RAS mutations (36.4% vs. 8.0%; p < 0.001), whereas FVPTC- with PTC-like methylation patterns were enriched for BRAFV600E mutations (52.0% vs. 0%, Fisher exact p = 0.004) and RET fusions (16.0% vs. 0%, Fisher exact p = 0.003). Conclusions: Our data provide novel insights into the epigenetic alterations of thyroid tumors. Since our classification method relies on a fully unsupervised machine learning approach for subtype discovery, our results offer a robust background to support the classification of thyroid neoplasms based on methylation patterns.
引用
- Marczyk VR, Recamonde-Mendoza M, Maia AL, et al. Classification of Thyroid Tumors Based on DNA Methylation Patterns. Thyroid. 2023. PMID: 37392021. doi:10.1089/thy.2023.0074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。